![]() |
市場調査レポート
商品コード
1451223
極低温冷凍庫市場レポート:製品タイプ、用途、最終用途産業、地域別、2024~2032年Cryogenic Freezers Market Report by Product Type, Application, End Use Industry, and Region 2024-2032 |
||||||
カスタマイズ可能
|
極低温冷凍庫市場レポート:製品タイプ、用途、最終用途産業、地域別、2024~2032年 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2~3営業日
|
世界の極低温冷凍庫市場規模は2023年に2億750万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに3億3,060万米ドルに達し、2024年から2032年の間に5.2%の成長率(CAGR)を示すと予測しています。生物学的サンプルの長期保存に対するバイオバンキング分野での需要の高まり、ゲノム研究における製品要件の増加、超低温保存ニーズの緊急性の高まりなどが市場を推進している要因の一部です。
極低温冷凍庫は、一般的に-150℃~-196℃(-238°F~-320°F)の超低温を維持するように設計された特殊な冷凍システムです。これらの冷凍庫は主に、血液、組織、細胞などの生物学的サンプルを、細胞の変化を最小限に抑えながら長期間保存するために設計されています。高度な断熱材と冷却技術で作られたこれらの装置は、超低温設定を効率的に達成し、維持します。冷媒として液体窒素や液体二酸化炭素を使用することが多いが、機械式もあります。これらの冷凍庫の仕組みは、通常2段階の冷凍プロセスで、第1段階で-40℃前後まで温度を下げ、第2段階で超低温を実現します。この二重冷却プロセスにより、温度変動が最小限に抑えられ、様々な研究、医療、産業用途で極めて重要な役割を担っています。
極低温冷凍庫の世界市場は、主に生物学的サンプルの長期保存を目的としたバイオバンキング分野での需要の高まりによって牽引されています。これに伴い、ゲノム研究における製品要件の増加も市場の展望を高めています。さらに、COVID-19パンデミックの中で超低温保存の必要性が高まっていることも、市場成長に寄与する重要な要因となっています。これに加えて、医薬品の有効性を維持するために製薬業界や医療業界で採用が拡大していることも、市場拡大を後押ししています。さらに、モノのインターネット(IoT)のような先進的なリアルタイム監視技術がこれらの冷凍庫に統合されていることも、市場の前向きな展望を示しています。医療や食品産業における効率的なコールドチェーン管理に対する厳しい規制要件も市場を後押ししています。これと並行して、医療研究における検体の完全性の重要性に対する認識が高まっていることも、市場導入を後押ししています。その他、信頼性の高い超低温保存を必要とする臓器移植の増加や、個別化医療への依存度の高まりなども市場に寄与しています。
医療調査と診断の進歩
極低温冷凍庫市場に影響を与える極めて重要な要因の1つは、医療研究と診断の進歩です。医療機関や研究機関が病気の分子レベルでの理解を深めるにつれ、生物学的サンプルを超低温で保存する必要性が最も重要になります。これにより精密な分析が可能になり、新たな治療法、薬、ワクチンの発見に道が開かれます。がん、アルツハイマー病、様々な感染症などの複雑な疾患に焦点を当てた研究プログラムが増加するにつれ、信頼性の高い大容量の極低温保存ソリューションへの需要が高まっています。ハイスループットスクリーニングや複雑なアッセイには、保存された大量の生物学的物質が必要です。超低温保存によってのみ、これらのサンプルを長期間生存可能な状態に保つことができ、何年にもわたる調査や生命を救う可能性のある研究の完全性を確保することができます。
規制監督と品質基準の強化
市場のもう一つの大きな促進要因は、世界中で規制監督と品質基準への注目が高まっていることです。生物学的サンプルの保管は単なる利便性の問題ではなく、しばしば規制上の要件となっています。生物試料の保管、マテリアルハンドリング、文書化の方法について、数カ国の数多くの機関がより厳しいガイドラインに直面しています。このような規制は、新薬の有効性と安全性を検討する臨床試験や製薬研究において特に厳しくなっています。このような規制に従わない場合、金銭的な罰則や評判の失墜など、厳しい影響が及ぶ可能性があります。したがって、これらの高品質基準を満たす極低温冷凍庫の採用は、オプションではなく、必要不可欠なものです。このような保管ソリューションを導入することで、コンプライアンスが保証され、それによってリスクが軽減され、より円滑な調査方法が促進されます。
バイオテクノロジー企業の世界的拡大
バイオテクノロジー企業の世界の拡大は、極低温冷凍庫市場を牽引する大きな力となっています。これらの企業が、国内市場だけでなく国際的な分野にも進出するようになるにつれ、堅牢で信頼性が高く、集中管理された極低温貯蔵ソリューションへの要求がますます重要になってきています。これらの企業は、ゲノムから個別化医療、さらには農業バイオテクノロジーに至るまで、複数の科学分野にまたがる画期的な研究開発や製品開発に携わっていることが多いです。このような広範な用途で使用される生物学的サンプルの価値は、金銭的価値と科学的有用性の両面で計り知れないです。企業の規模が拡大するにつれ、こうした生物学的資産の管理の複雑さも指数関数的に増大します。複数の場所で保管を標準化し、それぞれの管轄区域で必要な品質と安全性の規制を満たすようにすることは、ロジスティクス上の大きな課題となります。
The global cryogenic freezers market size reached US$ 207.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 330.6 Million by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The rising demand in bio-banking sectors for the long-term preservation of biological samples, increasing product requirements in genomic research, and rising urgency of ultra-low temperature storage needs represent some of the factors that are propelling the market.
A cryogenic freezer is a specialized refrigeration system engineered to maintain ultra-low temperatures, typically ranging from -150°C to -196°C (-238°F to -320°F). These freezers are principally designed to preserve biological samples, such as blood, tissues, and cells, for extended periods while minimizing cellular changes. Built with advanced insulation materials and cooling technologies, these units efficiently attain and sustain their ultra-low temperature settings. They often employ liquid nitrogen or liquid carbon dioxide as the refrigerant, although mechanical systems are also available. The mechanism behind these freezers involves a two-stage refrigeration process; the first stage usually brings the temperature down to around -40°C, and the subsequent stage achieves the ultra-low temperature. This double-cooling process ensures minimal thermal fluctuations, making these freezers pivotal in various research, medical, and industrial applications.
The global market for cryogenic freezers is primarily driven by the rising demand in bio-banking sectors for the long-term preservation of biological samples. In line with this, the increasing product requirements in genomic research are also elevating the market's prospects. Moreover, the rising urgency of ultra-low temperature storage needs amid the COVID-19 pandemic acts as a significant factor contributing to market growth. In addition to this, the growing adoption within the pharmaceutical and healthcare industries to preserve drug efficacy is also propelling market expansion. Furthermore, the integration of advanced, real-time monitoring technologies such as the internet of things (IoT) into these freezers presents a positive market outlook. The market is also fueled by stringent regulatory requirements for efficient cold chain management in healthcare and food industries. Alongside this, greater awareness regarding the importance of specimen integrity in medical research is driving market adoption. Some of the other factors contributing to the market include the increasing number of organ transplants that require reliable ultra-low temperature storage, and the growing reliance on personalized medicine.
Advances in Medical Research and Diagnostics
One pivotal factor influencing the market for cryogenic freezers is the advancements in medical research and diagnostics. As healthcare institutions and research organizations delve deeper into understanding diseases at a molecular level, the need for storing biological samples at ultra-low temperatures becomes paramount. This enables precise analyses and paves the way for the discovery of new treatment methods, medications, and vaccines. As we see an increase in the number of research programs focused on complex diseases such as cancer, Alzheimer's, and various infectious diseases, the demand for reliable and high-capacity cryogenic storage solutions grows. High-throughput screenings and complex assays require large volumes of preserved biological matter. Only with ultra-low temperature storage can these samples be kept viable for extended periods, ensuring the integrity of years-long studies and potentially life-saving research.
Increased regulatory oversight and quality standards
Another major driver for the market is the intensified focus on regulatory oversight and quality standards across the globe. The storage of biological samples is not just a matter of convenience but often a regulatory requirement. Numerous institutions in several countries are facing stricter guidelines about how biological materials should be stored, handled, and documented. Such regulations are particularly rigorous in clinical trials and pharmaceutical research where the efficacy and safety of new drugs are examined. Non-compliance with these regulations can lead to severe repercussions, including financial penalties and loss of reputation. Therefore, the adoption of cryogenic freezers that meet these high-quality standards is not optional but essential. The implementation of such storage solutions assures compliance, thereby mitigating risks and facilitating a smoother research process.
Global expansion of biotechnology firms
The worldwide expansion of biotechnology firms is a substantial force driving the cryogenic freezers market. As these organizations broaden their reach, moving beyond domestic markets into international arenas, the requirement for robust, reliable, and centralized cryogenic storage solutions becomes ever more crucial. These firms are often involved in groundbreaking research and product development activities that span multiple scientific disciplines, from genomics to personalized medicine and even agricultural biotechnology. The value of the biological samples used in such wide-ranging applications is immense, both in terms of financial worth and scientific utility. As the company scales, the complexity of managing these biological assets also increases exponentially. Standardizing storage across multiple locations, while ensuring each meets the necessary quality and safety regulations of their respective jurisdictions, becomes a logistical challenge of significant proportions.
IMARC Group provides an analysis of the key trends in each segment of the global cryogenic freezers market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, application and end use industry.
Tunnel Freezer
IQF Freezer
Immersion Freezer
Spiral Freezer
Others
Tunnel freezer represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the product type. This includes tunnel freezer, IQF freezer, immersion freezer, spiral freezer and others. According to the report, tunnel freezer represented the largest segment.
The tunnel freezer segment in the cryogenic freezers market is primarily driven by the increasing demand for fast and efficient freezing solutions in the food and beverage industry. These freezers offer large-scale freezing capacity, which makes them ideal for industrial applications. The rise in the adoption of automation in food processing facilities is contributing to the segment's growth. Additionally, stringent food safety regulations are pushing manufacturers to invest in reliable and quick freezing solutions. Environmental benefits, such as lower energy consumption compared to traditional methods, further boost the segment's attractiveness.
On the other hand, IQF, immersion, and spiral freezers are gaining traction due to their specialized applications in sectors like seafood, fruits, and vegetables. These freezers offer the advantage of freezing individual items quickly, thus maintaining quality. Innovative technological advancements in these freezers are also contributing to market growth.
Corporate Laboratories
Hospitals and Blood Centers
Universities and Research Institutions
Others
Hospitals and blood centers represent the largest market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes corporate laboratories, hospitals and blood centers, universities and research institutions, and others. According to the report, hospitals and blood centers represented the largest segment.
The hospitals and blood centers segment in the cryogenic freezers market is largely propelled by the increasing need for the safe storage of blood, organs, and other biological samples. These freezers are essential for preserving the viability of these biological materials for extended periods. Rising awareness about blood donation and the expansion of healthcare infrastructure globally are other significant factors driving this segment. Strict regulatory guidelines for medical storage conditions also influence the adoption rate of cryogenic freezers in hospitals. Aging populations and the growing prevalence of chronic diseases necessitate more advanced freezing solutions, augmenting market demand.
On the other hand, corporate laboratories, universities, and research institutions employ cryogenic freezers for purposes like tissue storage and long-term biological research. Technological advancements in research methods and the rise in R&D funding contribute to the growth of these segments.
Food and Beverages
Medical and Healthcare
Pharmaceuticals
Chemicals
Others
Medical and healthcare accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the end use industry. This includes food and beverages, medical and healthcare, pharmaceuticals, chemicals, and others. According to the report, medical and healthcare represented the largest segment.
The medical and healthcare segment is a prominent driver in the cryogenic freezers market, buoyed by factors like rising pharmaceutical research, the growing requirement for long-term storage of medical supplies, and increasing healthcare expenditure. Enhanced focus on personalized medicine also requires advanced freezing solutions for storing specialized therapies and diagnostics. In addition, the growth in organ transplant procedures globally necessitates reliable freezing technologies for organ preservation. The COVID-19 pandemic has especially emphasized the importance of secure storage solutions for vaccines and other critical medical supplies. The ongoing development and distribution of vaccines also play a pivotal role in boosting this segment.
On the other hand, the food and beverages, pharmaceuticals, and chemicals sectors utilize cryogenic freezers for specific, often specialized, applications. These include the preservation of flavor profiles in food items, storing sensitive pharmaceutical compounds, and maintaining the stability of chemical substances.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
North America exhibits a clear dominance, accounting for the largest cryogenic freezers market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America; Europe; Asia Pacific; the Middle East and Africa; and Latin America. According to the report, North America accounted for the largest market share.
The North America region holds a significant share in the global cryogenic freezers market, driven by factors such as advanced healthcare infrastructure, robust food processing industries, and high R&D spending in both academic and corporate sectors. The presence of major market players in the region also contributes to its dominance.
In addition to this, the increasing awareness regarding blood and organ donations fuels the market, especially in healthcare applications. Regulatory compliance is another key driver, with institutions following strict guidelines for storage solutions. In addition to healthcare, the North American food industry's adoption of high-throughput, automated freezing solutions contributes to market growth.
With the United States and Canada leading in both healthcare and food processing sectors, it significantly influences market trends. Also, the COVID-19 pandemic and the rising prevalence of numerous related diseases has resulted in a significant demand for cryogenic freezers for vaccine storage. Furthermore, the rise in personalized medicine and the adoption of innovative technologies in freezing solutions continue to offer growth opportunities in this region.
The leading companies are making strides in technology to offer better temperature control and energy-efficient solutions. They are collaborating with healthcare and research institutions to understand their specific needs, thereby customizing their product offerings. Emphasis is laid on providing smart features like remote monitoring and data logging to offer added convenience to users. These key players are also exploring emerging markets and establishing distribution channels to widen their global footprint. Investments are made in automation to increase production efficiency and reduce operational costs. Attention is paid to adhering to international quality and safety standards, giving them a competitive edge. Partnerships are often established with local vendors for quicker service and maintenance. These companies are also actively involved in mergers and acquisitions to diversify their product portfolios and expertise.
Thermo Fisher Scientific Inc.
Panasonic Corporation
Chart Industries, Inc.
Haier Group
DAIHAN Scientific
Froilabo
Arctiko
Taylor-Wharton
VRV Group
Aucma Co., Ltd.
Zhongke Meiling Cryogenics Company Limited
In August 2023, Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT Solution, after receiving IVDR certification. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma.
In July 2023, Panasonic Corporation introduced Kinari, a sustainable alternative to traditional plastics. Developed by a team of eco-conscious engineers, Kinari is a high-density material made from cellulose fibers sourced from waste plant materials, bonded with a minimal amount of oil-based resin. The innovation aims to advance sustainability and contribute to a circular society.
In July 2023, Chart Industries, Inc. and New Zealand's Fabrum have partnered to produce and sell Micro-Scale Liquefiers aimed at meeting the growing demand for hydrogen and other gas liquefaction systems. These liquefiers support small-scale liquid hydrogen production and have applications in sustainable transport, industrial use, and energy self-sufficiency.